Quinoline and thiazolopyridine allosteric inhibitors of MALT1
-
Add time:08/30/2019 Source:sciencedirect.com
Quinolines and thiazolopyridines were developed as allosteric inhibitors of MALT1, with good cellular potency and exquisite selectivity. Mouse pharmacokinetic (PK) profiling showed these to have low in vivo clearance, and moderate oral exposure. The thiazolopyridines were less lipophilic than the quinolines, and one thiazolopyridine example was active in our hIL10 mouse pharmacodynamic (PD) model upon oral dosing.
We also recommend Trading Suppliers and Manufacturers of 8-ETHYL QUINOLINE (cas 19655-56-2). Pls Click Website Link as below: cas 19655-56-2 suppliers
Prev:Mini-review1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents
Next:Review articleGreen recipes to quinoline: A review) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Full Length ArticleCatalysed oxidation of quinoline in model fuel and the selective extraction of quinoline-N-oxide with imidazoline-based ionic liquids09/05/2019
- Investigation of new quinoline derivatives as promising inhibitors of NTPDases: Synthesis, SAR analysis and molecular docking studies09/04/2019
- Research paperDesign, synthesis and biological evaluation of new quinoline derivatives as potential antitumor agents09/03/2019
- Synthesis and evaluation of Quinoline-3-carbonitrile derivatives as potential antibacterial agents09/02/2019
- High-contrast mechanofluorochromism and acidochromism of D-π-A type quinoline derivatives09/01/2019
- Review articleGreen recipes to quinoline: A review08/31/2019
- Mini-review1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents08/29/2019
-
Health and Chemical more >